Research programme: apoptosis inducers - AdamedAlternative Names: ONCO-3CLA
Latest Information Update: 08 Jan 2014
At a glance
- Originator Adamed
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 08 Jan 2014 Research programme: apoptosis inducers - Adamed is available for licensing as of 08 Jan 2014. http://www.adamed.com.pl
- 06 Jan 2014 Early research in Solid tumours in Poland (unspecified route)